Contrasting Editas Medicine (EDIT) & NewLink Genetics (NLNK) – StockNewsTimes
StockNewsTimes |
Contrasting Editas Medicine (EDIT) & NewLink Genetics (NLNK)
StockNewsTimes It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 … Financial Newsletter – Zacks |
